Home / Resources / Early Clinical resources

早期临床

最新资源

Certara Expands Simcyp® Simulator to Streamline Regulatory Submissions and Internal Efficiencies

Certara Expands Simcyp® Simulator to Streamline Regulatory Submissions and Internal Efficiencies

Understanding and Calculating Steady State Pharmacokinetics

Understanding and Calculating Steady State Pharmacokinetics

Blog, Knowledge Base

How does Pinnacle 21 Enterprise differ from the Community version?

How does Pinnacle 21 Enterprise differ from the Community version?

精选资源

ADC First-in-Human (FIH) Dose Selection: Designing FIH Studies for Success

ADC 首次人体（FIH）剂量选择：成功设计 FIH 研究的关键

Upcoming early clinical webinars

网络研讨会

充分发挥 PBPK 模型的全部潜力以加速药物研发

3 月 11 日，4 月 9 日

网络研讨会

Non-compartmental analysis of statin pharmacokinetics in pharmacogenetics research

2026 年 3 月 11 日 – 10:00 -10:45 AM ET

网络研讨会

CHI ADC Webinar Series: From First-in-Human Dose Selection to Label Optimization, Commercial Expansion, and Market Access

Mar 17, Apr 2 – 11am - 12pm ET

Latest early clinical blogs

All Early clinical - Blog

药物开发中 PK/PD 建模的机器学习

美国 FDA MIDD 配对试点计划如何帮助赞助商

揭秘临床 DDI 研究：精准测量代谢产物

为何 FDA 批准 omaveloxolone 用于治疗弗里德赖希共济失调症意义重大

细胞疗法开发的主要考虑因素

降低药物开发风险：早期开发中的关键化学、制造和控制（CMC）及基于生理的药代动力学（PBPK）方法

在以下活动中与我们的专家会面

ACDM 2026

2026 年 3 月 15 - 17 日 - 德国柏林 - Booth 13

Apotekarsocieteten 临床药理学策略在药物开发中的应用

2026 年 3 月 17 日

SOT Annual Meeting and ToxExpo 2026

March 22 - 25, 2026 – San Diego, CA – Booth 2024

All early clinical resources

Building Trust in Data – Transparency, Traceability, and the Human Element

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, Drug Development, Webinar

Understanding and Calculating Steady State Pharmacokinetics

Certara 产品 - Phoenix，建模和模拟 - PK/PD，博客，知识库

How does Pinnacle 21 Enterprise differ from the Community version?

Certara Products - Pinnacle 21, Blog

ADC 首次人体（FIH）剂量选择：成功设计 FIH 研究的关键

ADC, Biologics, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Therapeutic Specialties, Blog

Apotekarsocieteten 临床药理学策略在药物开发中的应用

Certara Services, Clinical Pharmacology, Drug Development, Drug-Drug Interactions (DDI), Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Conference

Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)

Certara Products - Phoenix, Clinical Pharmacology, Modeling and Simulation - PK/PD, On-Demand Webinar

Marbach DDI Workshop 2026

Certara Products - Simcyp, Drug-Drug Interactions (DDI), Modeling and Simulation - PBPK, Conference

Rare Disease Day 2026: Accelerating Rare Disease Drug Development Through Cross-Functional Innovation

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Rare and Neglected Diseases, Blog

Metatdata as Infrastructure: Designing for Reuse, Insight, and Auditability

Certara Products - Pinnacle 21, Clinical Trials, Data Standards, On-Demand Webinar

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Certara Products - Certara IQ, Certara Products - Phoenix, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

Start right, finish strong: 抗体-药物偶联物（ADC）研究成功之道

ADC, Biologics, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - QSP, On-Demand Webinar

Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs)

Certara Products - Certara IQ, Certara Products - Phoenix, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar

1
2
3
……
64
›

订阅时事通讯

为什么订阅？因为改变药物开发不仅是我们的目标，更是我们的执着追求。如果这也是您的想法，那么请第一时间了解新见解，与我们一起推动科学发展。

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software